About James McNulty
Form D filings for Telomir Pharmaceuticals in 2023 list James McNulty as treasurer, chief financial officer and secretary.
James McNulty first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name James McNulty in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James McNulty works with at each company, as listed on that company's latest Form D.
Telomir Pharmaceuticals, Inc. · Form D, Apr 3, 2023
TT
Tuck Talhia
Director
CE
Craig Eagle
Director
DV
David Vorhoff
Director
CC
Chris Chapman
President, Chief Executive Officer and Chairman
HM
Hugh McColl
Director
JU
Jude Uzonwanne
Director